Recently, Respiratory Technology Corporation (dba Restech) announced that the Restech Dx-pH Measurement System was part of a study to accurately measure pharyngeal acid exposure conducted by the Advanced Esophageal Function Laboratory of the University of Southern California (USC). The study, 24-hour Pharyngeal pH Measurement?, was conducted under the direction of Tom R. DeMeester, MD, FACS, FACG, Chair, Department of Surgery, University of Southern California.

The prevalence of obesity and overweight in the United States coupled by the increased risk of gastrointestinal diseases related to obesity raises serious implications for the health of Americans. Several scientific studies in the August issue of The American Journal of Gastroenterology examine the association between obesity and the risk of colorectal cancer and gastroesophageal reflux disease, or GERD. Dr. Frank K.

Patients who use proton pump inhibitors for 7 or more years to treat reflux, peptic ulcers and other conditions are at greater risk of osteoporosis-related fractures, according to this large observational study, http://www.cmaj.ca/press/pg319.pdf, of 15,792 patients published in CMAJ.

A pre-cancerous condition linked to chronic acid reflux often gets overlooked. Can the medical community do a better job intervening? Researchers from the Hutchinson-MRC Research Centre in Cambridge think so. In a review published in the inaugural issue of Disease Models & Mechanisms (DMM), http://dmm.biologists.